Assignee profile:

Respivant Sciences GmbH

City:

Basel

Country:

Switzerland

Published Applications:

11

Last publication date:

2020-05-21

Patent Grants:

10

Last grant date:

2020-11-17

Top Inventors for applications by Respivant Sciences GmbH

These are the the leading inventors for applications assigned to Respivant Sciences GmbH:

Recent patent applications by Respivant Sciences GmbH

Respivant Sciences GmbH based in Basel, CH has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2020-05-21
US20200155452A1
Human necessities

Cromolyn Compositions for Treatment of Chronic Cough Due to Idiopathic Pulmonary Fibrosis

#2 | 2019-10-31 ✅ Patent 10,835,512 granted on 2020-11-17
US20190328700A1
Human necessities

Methods of treating respiratory syncytial virus infections

#3 | 2019-07-25 ✅ Patent 10,583,113 granted on 2020-03-10
US20190224162A1
Human necessities

Cromolyn compositions for treatment of pulmonary fibrosis

#4 | 2019-07-25 ✅ Patent 10,561,635 granted on 2020-02-18
US20190224161A1
Human necessities

Cromolyn compositions for treatment of pulmonary fibrosis

#5 | 2019-06-20 ✅ Patent 10,596,146 granted on 2020-03-24
US20190183847A1
Human necessities

Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders

#6 | 2019-06-20 ✅ Patent 10,391,078 granted on 2019-08-27
US20190183846A1
Human necessities

Methods for the treatment of mast cell related disorders with mast cell stabilizers

#7 | 2019-06-13 ✅ Patent 10,463,613 granted on 2019-11-05
US20190175503A1
Human necessities

Cromolyn compositions for treatment of chronic cough due to idiopathic pulmonary fibrosis

#8 | 2018-09-27 ✅ Patent 10,238,628 granted on 2019-03-26
US20180271828A1
Human necessities

Mast cell stabilizers treatment for systemic disorders

#9 | 2018-08-16 ✅ Patent 10,265,296 granted on 2019-04-23
US20180228762A1
Human necessities

Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders

#10 | 2018-08-16 ✅ Patent 10,238,625 granted on 2019-03-26
US20180228761A1
Human necessities

Methods for the treatment of mast cell related disorders with mast cell stabilizers

#11 | 2018-07-12 ✅ Patent 10,265,267 granted on 2019-04-23
US20180193259A1
Human necessities

Cromolyn compositions for treatment of chronic cough due to idiopathic pulmonary fibrosis

Also check out Respivant Sciences GmbH's (Basel, Switzerland) applicant profile with 11 patent applications submitted.

AssigneeID:

158408 ⎘